General Information
Drug ID
DR00983
Drug Name
Azacitidine
Synonyms
2-(beta-D-Ribofuranosyl)-4-amino-1,3,5-triazin-2-one; 4-Amino-1-(beta-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one; 4-Amino-1-beta-D-ribofuranosyl-1,3,5-traizin-2(1H)-one; 4-Amino-1-beta-D-ribofuranosyl-1,3,5-triazine-2(1H)-one; 4-Amino-1-beta-D-ribofuranosyl-s-triazin-2(1H)-one; 4-Amino-1-beta-d-ribofuranosyl-1,3,5-triazin-2(1H)-one; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triaz; 4-amino-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,3,5-triazin-2-one; 4-amino-1-beta-L-ribofuranosyl-1,3,5-triazin-2(1H)-one; 5 AZC; 5 Azacytidine; 5-AC; 5-AZAC; 5-AZCR; 5-aza-CR; 5-azacitidine; 5-azacytidine; 5-azacytidine, Mylosar, Ladakamycin, Vidaza, Azacitidine; 5AzaC; Antibiotic U 18496; Azacitidina; Azacitidina [INN-Spanish]; Azacitidine (JAN/USAN/INN); Azacitidine [USAN:INN]; Azacitidinum; Azacitidinum [INN-Latin]; Azacytidine; Ladakamycin; Mylo sar; Mylosar; NS-17; Pharmion Brand of Azacitidine;A 2385; Pyrimidine antimetabolite: inhibits nucleic acid replication; S-Triazin-2(1H)-one, 4-amino-1-beta-D-ribofuranosyl-(8CI); U 18496; U-18496; Vidaz (TN); Vidaza; Vidaza (TN); WR-183027; Wr 183027
Drug Type
Small molecular drug
Therapeutic Class
Anticancer Agents
Structure
3D MOL 2D MOL
Formula
C8H12N4O5
Canonical SMILES
C1=NC(=NC(=O)N1C2C(C(C(O2)CO)O)O)N
InChI
InChI=1S/C8H12N4O5/c9-7-10-2-12(8(16)11-7)6-5(15)4(14)3(1-13)17-6/h2-6,13-15H,1H2,(H2,9,11,16)/t3-,4-,5-,6-/m1/s1
InChIKey
NMUSYJAQQFHJEW-KVTDHHQDSA-N
CAS Number
CAS 320-67-2
Pharmaceutical Properties Molecular Weight 244.2 Topological Polar Surface Area 141
Heavy Atom Count 17 Rotatable Bond Count 2
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 5
XLogP
-2.2
PubChem CID
9444
ChEBI ID
ChEBI:2038
TTD Drug ID
D09FAZ

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.